EXICURE, INC.
EXICURE, INC. (XCUR): 2 pipeline candidates · ~8 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
7.6 months
D/E 5.08 · 0% dilution
Lead: Phase 2
2 candidates
N/A
0 buys · 3 sells (180d)
A transparent, data-derived signal for EXICURE, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$14.3M
Cash
$2.6M
Quarterly Burn
$1.1M
Runway
7.6 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| cavrotolimod | Preclinical |
| gpc-100 | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
14
Total value held
$582K
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 65,966 | $282K |
| geode capital management, llc | 36,913 | $158K |
| vanguard fiduciary trust co | 13,161 | $56K |
| northern trust corp | 10,686 | $45K |
| blackrock, inc. | 9,353 | $40K |
| morgan stanley | 158 | $672 |
| sbi securities co., ltd. | 43 | $183 |
| osaic holdings, inc. | 29 | $123 |
| prestige wealth management group llc | 20 | $86 |
| harbour investments, inc. | 17 | $72 |
Showing top 10 of 14 institutional holders of EXICURE, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in EXICURE, INC.'s pipeline?
EXICURE, INC. (XCUR) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is EXICURE, INC.'s lead drug candidate?
EXICURE, INC.'s most advanced tracked candidate is cavrotolimod (Preclinical) for hepatitis.
What is EXICURE, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, EXICURE, INC. has approximately 7.6 months of cash runway.
What is EXICURE, INC.'s market capitalization?
EXICURE, INC.'s market capitalization is approximately $14.3M.
Who is the CEO of EXICURE, INC.?
Mr. Jungsoo Kim is the chief executive officer of EXICURE, INC. (XCUR).
Get the full picture on EXICURE, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.